Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

NCT03850483 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: PF-06700841
DRUG: Vehicle (Placebo)

Sponsor

Pfizer